Pfizer Stops China Vaccine Sales as Import License Expires

April 2, 2015 1:29 PM

66 0

Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.

The world's second-biggest drugmaker by revenue says it stopped sales immediately, a decision that affected about 200 of Pfizer's 9,000 employees in China. The vaccine is labeled Prevenar in China and other countries.

Read more

To category page